132 related articles for article (PubMed ID: 12804566)
1. High levels of urinary midkine in various cancer patients.
Ikematsu S; Okamoto K; Yoshida Y; Oda M; Sugano-Nagano H; Ashida K; Kumai H; Kadomatsu K; Muramatsu H; Takashi Muramatsu ; Sakuma S
Biochem Biophys Res Commun; 2003 Jun; 306(2):329-32. PubMed ID: 12804566
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873
[TBL] [Abstract][Full Text] [Related]
3. Serum midkine levels are increased in patients with various types of carcinomas.
Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
[TBL] [Abstract][Full Text] [Related]
4. Serum midkine concentrations and gastric cancer.
Obata Y; Kikuchi S; Lin Y; Yagyu K; Muramatsu T; Kumai H;
Cancer Sci; 2005 Jan; 96(1):54-6. PubMed ID: 15649256
[TBL] [Abstract][Full Text] [Related]
5. Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas.
Aridome K; Takao S; Kaname T; Kadomatsu K; Natsugoe S; Kijima F; Aikou T; Muramatsu T
Br J Cancer; 1998 Aug; 78(4):472-7. PubMed ID: 9716029
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas.
Muramatsu H; Song XJ; Koide N; Hada H; Tsuji T; Kadomatsu K; Inui T; Kimura T; Sakakibara S; Muramatsu T
J Biochem; 1996 Jun; 119(6):1171-5. PubMed ID: 8827454
[TBL] [Abstract][Full Text] [Related]
7. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of midkine expression in pancreatic head carcinoma.
Maeda S; Shinchi H; Kurahara H; Mataki Y; Noma H; Maemura K; Aridome K; Yokomine T; Natsugoe S; Aikou T; Takao S
Br J Cancer; 2007 Aug; 97(3):405-11. PubMed ID: 17622248
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level.
Çetin Sorkun H; Akbulut M; Enli Y; Tepeli E; Özkan S; Erdem E
Turk J Med Sci; 2016 Jan; 46(1):219-27. PubMed ID: 27511357
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors.
Kato S; Ishihara K; Shinozawa T; Yamaguchi H; Asano Y; Saito M; Kato M; Terada T; Awaya A; Hirano A; Dickson DW; Yen SH; Ohama E
J Neuropathol Exp Neurol; 1999 May; 58(5):430-41. PubMed ID: 10331431
[TBL] [Abstract][Full Text] [Related]
11. Two clusters of serum midkine levels in drug-naive patients with schizophrenia.
Shimizu E; Hashimoto K; Salama RH; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Nakazato M; Kumakiri C; Okada S; Muramatsu H; Muramatsu T; Iyo M
Neurosci Lett; 2003 Jun; 344(2):95-8. PubMed ID: 12782336
[TBL] [Abstract][Full Text] [Related]
12. Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas.
Ikematsu S; Nakagawara A; Nakamura Y; Sakuma S; Wakai K; Muramatsu T; Kadomatsu K
Br J Cancer; 2003 May; 88(10):1522-6. PubMed ID: 12771916
[TBL] [Abstract][Full Text] [Related]
13. Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders.
Yoshida Y; Ikematsu S; Muramatsu H; Sakakima H; Mizuma N; Matsuda F; Sonoda K; Umehara F; Ohkubo R; Matsuura E; Goto M; Osame M; Muramatsu T
Intern Med; 2008; 47(2):83-9. PubMed ID: 18195496
[TBL] [Abstract][Full Text] [Related]
14. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
[TBL] [Abstract][Full Text] [Related]
15. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
Jones DR
Br J Pharmacol; 2014 Jun; 171(12):2925-39. PubMed ID: 24460734
[TBL] [Abstract][Full Text] [Related]
16. Increased serum midkine levels during hemodialysis using heparin in chronic renal failure.
Fujisawa K; Matsumoto Y; Muramatsu H; Shinzato T; Hiramatsu K; Horie K; Cai Z; Oka H; Amano I; Muramatsu T; Maeda K
J Biochem; 1998 May; 123(5):864-9. PubMed ID: 9562618
[TBL] [Abstract][Full Text] [Related]
17. The expression and location of midkine in gastric carcinomas of Chinese patients.
Huang Y; Cao G; Wang H; Wang Q; Hou Y
Cell Mol Immunol; 2007 Apr; 4(2):135-40. PubMed ID: 17484808
[TBL] [Abstract][Full Text] [Related]
18. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis.
Maruyama K; Muramatsu H; Ishiguro N; Muramatsu T
Arthritis Rheum; 2004 May; 50(5):1420-9. PubMed ID: 15146411
[TBL] [Abstract][Full Text] [Related]
19. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids.
Soulié P; Héroult M; Bernard I; Kerros ME; Milhiet PE; Delbé J; Barritault D; Caruelle D; Courty J
J Immunoassay Immunochem; 2002; 23(1):33-48. PubMed ID: 11848100
[TBL] [Abstract][Full Text] [Related]
20. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y
Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
